RCS - Brandshield Systems - Further Contract Win in Pharmaceutical Sector

Brandshield Systems

30/06/2021 07:00

RNS Number : 5464D

Brandshield Systems PLC

30 June 2021

 

30 June 2021

BrandShield Systems plc

("BrandShield", or the "Company")

Further BrandShield Contract Win in Pharmaceutical Sector  

 

BrandShield Systems plc (AIM: BRSD), a leading provider of cybersecurity solutions from brand protection to online threat hunting, is pleased to announce that it has completed a contract with a further customer in the pharmaceutical industry. This follows previous pharmaceutical sector contracts with the Pharmaceutical Security Institute and Bristol Myers Squibb announced in November 2020 and December 2020 respectively. It is one of a number of additional clients secured in June over and above the 18 new clients BrandShield secured between January and May 2021 which the Company revealed alongside the publication of its 2020 Accounts on 21 June 2021.

 

The customer, which is based in Europe, has signed an annual recurring contract with BrandShield to protect several of its drugs from online threats which have become increasingly prevalent during the COVID-19 crisis. These threats cut across standalone websites, social media platforms and ecommerce marketplaces. 

 

Yoav Keren, co-founder and CEO of BrandShield, added: ""The pharmaceutical industry is probably the most complex category in brand protection and requires inter-disciplinary expertise. Companies operating in the sector are affected from threats across the entire external cyber security spectrum that BrandShield covers, those being phishing, fraud, impersonation, counterfeit sales, social phishing and brand abuse. It is critical given the fact that the brand protection risk in the pharmaceutical sector is directly connected to public safety and therefore requires a holistic solution. BrandShield has proven capabilities to provide a comprehensive solution from the detection of the threats through to their takedown using its state of the art SaaS platform. BrandShield already protects over one hundred different pharmaceutical brands and drugs online. The Company believes this growth trend will continue and BrandShield will lead the protection effort in this category, amongst others".

 

For further information please visit https://www.brandshield.com/ or contact: 

BrandShield Systems plc
Yoav Keren, CEO
+44 (0)20 3143 8300
Spark Advisory Partners Limited (Nominated Adviser)
Neil Baldwin / Andrew Emmott / James Keeshan
+44 (0)20 3368 3554
Shore Capital (Joint Broker)
Toby Gibbs / James Thomas / Sarah Mather (Corporate Advisory)
Henry Willcocks (Corporate Broking)
+44 (0)20 7408 4090
Tennyson Securities (Joint Broker)
Peter Krens
+44 (0)20 7186 9033
VSC (PR Agency US)
Justin Higgins
JustinH@vsc.co

- ENDS -

 

 

About BrandShield

BrandShield is a leading cybersecurity company founded in Israel by cybersecurity experts that protect the world's largest brands and consumers from phishing attacks, online fraud, and other online threats posed by dangerous cybercriminals. Through its AI/ML platform, BrandShield identifies, tracks, and eliminates online threats for global brands and organizations, including Bristol Myers Squibb, Levi's, NewBalance, Swisscom, and the Pharmaceutical Security Institute. BrandShield is listed on the London Stock Exchange AIM under ticker symbol BRSD. To learn more about BrandShield, please visit the company website at www.BrandShield.com.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

For more information, please contact:

 

E: brandshielduk@balloupr.com 

 

Ross Copping

T: 020 3983 8298

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
NRAPPUMAQUPGGAB